News
October 20, 2022

Regenstrief, IDOH collaborating on flu data and analysis for public health

Federal funding supports continuation of exceptional public-private partnership

Regenstrief Institute and the Indiana Department of Health are collaborating on an influenza surveillance data pilot study to provide in-depth data and analysis of the spread of Influenza in Indiana, similar to how Regenstrief has provided data on COVID-19.

The data will be presented as a key component to inform state and local leaders as they address the health and welfare of Hoosiers during the flu season. Goals for the data include identifying patterns and hot spots throughout Indiana. The added capabilities will signal governmental and health systems’ leadership to enhance resources and patient care in specific areas of Indiana accordingly.

The partnership is supported by a $100,000 grant from the Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists.

“The Regenstrief Institute and Indiana Department of Health partnership has been a highly effective in responding to the COVID pandemic,” said Shaun Grannis, M.D., M.S., vice president for data and analytics for Regenstrief. “This project is important to the health of Hoosiers and is a testament to the quality of the work that these two teams are capable of, including compiling and analyzing large amounts of data to enhance public health in Indiana.

“This is a natural continuation of this exceptional, long-term partnership,” Dr. Grannis continued. “The State Department of Health and Regenstrief have worked together on a number of high profile and impactful initiatives, including Indiana’s COVID response, the public health emergency surveillance system, electronic laboratory reporting, human papillomavirus (HPV) education, traumatic brain injury and a number of other consequential projects important to Indiana and beyond.”

A team including Regenstrief and IDOH is meeting on a regular basis to review, categorize and analyze data and inform stakeholders.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

 

Related News

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists and fellows shared work on artificial intelligence, health information exchange and public health informatics at

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight